M. Jansen

4.4k total citations
55 papers, 3.3k citations indexed

About

M. Jansen is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, M. Jansen has authored 55 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 28 papers in Endocrinology, Diabetes and Metabolism and 16 papers in Genetics. Recurrent topics in M. Jansen's work include Growth Hormone and Insulin-like Growth Factors (21 papers), Sexual Differentiation and Disorders (11 papers) and Birth, Development, and Health (9 papers). M. Jansen is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (21 papers), Sexual Differentiation and Disorders (11 papers) and Birth, Development, and Health (9 papers). M. Jansen collaborates with scholars based in Netherlands, United States and Hungary. M. Jansen's co-authors include J.S. Sussenbach, J. L. Van den Brande, F.M.A. van Schaik, Anita C. S. Hokken‐Koelega, Paul Mulder, Maarten Reeser, Mieke Houdijk, P. de Pagter-Holthuizen, Theo Sas and S. C. van Buul-Offers and has published in prestigious journals such as Nature, The Lancet and The Journal of Immunology.

In The Last Decade

M. Jansen

53 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Jansen Netherlands	29	1.7k	1.6k	1.1k	749	366	55	3.3k
Marsha L. Davenport United States	27	1.1k 0.7×	1.2k 0.7×	1.2k 1.1×	422 0.6×	147 0.4×	52	2.9k
Ora Hirsch Pescovitz United States	40	2.0k 1.2×	1.6k 1.0×	970 0.9×	562 0.8×	1.3k 3.6×	137	4.6k
Claudine Heinrichs Belgium	30	1.1k 0.7×	1.1k 0.7×	907 0.8×	614 0.8×	288 0.8×	88	2.6k
Guy Van Vliet Canada	46	3.7k 2.2×	2.7k 1.7×	1.8k 1.6×	1.3k 1.7×	586 1.6×	185	6.6k
J. L. Van den Brande Netherlands	26	2.1k 1.3×	1.6k 1.0×	1.1k 1.0×	483 0.6×	145 0.4×	81	3.7k
Jean‐Louis Chaussain France	41	2.1k 1.2×	2.1k 1.3×	1.6k 1.4×	669 0.9×	882 2.4×	106	4.3k
Tomonobu Hasegawa Japan	41	2.0k 1.2×	3.2k 2.0×	2.1k 1.9×	631 0.8×	868 2.4×	360	6.1k
Alicia Belgorosky Argentina	30	1.2k 0.7×	1.1k 0.7×	917 0.8×	322 0.4×	561 1.5×	127	2.5k
Geri Méduri France	40	1.0k 0.6×	1.5k 0.9×	1.1k 1.0×	223 0.3×	1.7k 4.7×	93	4.2k
R Rappaport France	30	997 0.6×	857 0.5×	645 0.6×	509 0.7×	449 1.2×	129	2.5k

Countries citing papers authored by M. Jansen

Since Specialization

Citations

This map shows the geographic impact of M. Jansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Jansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Jansen more than expected).

Fields of papers citing papers by M. Jansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Jansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Jansen. The network helps show where M. Jansen may publish in the future.

Co-authorship network of co-authors of M. Jansen

This figure shows the co-authorship network connecting the top 25 collaborators of M. Jansen. A scholar is included among the top collaborators of M. Jansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Jansen. M. Jansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jansen, Casper, Luuk Otterspoor, Mieke van den Heuvel, et al.. (2025). Structuring telemonitoring in heart failure care in The Netherlands: design and operational protocol of a nationwide initiative. European Heart Journal - Digital Health. 7(2). ztaf130–ztaf130.

Jansen, M., et al.. (2025). Beyond GMV: the relevance of covariance matrix estimation for risk-based portfolio construction. Quantitative Finance. 25(3). 403–419.

Gaga, Mina, Joanna Chorostowska‐Wynimko, Ildikó Horváth, et al.. (2020). Validation of Lung EpiCheck, a novel methylation-based blood assay, for the detection of lung cancer in European and Chinese high-risk individuals. European Respiratory Journal. 57(1). 2002682–2002682. 38 indexed citations

Menke, Leonie A., Theo Sas, Sabine M.P.F. de Muinck Keizer‐Schrama, et al.. (2010). Efficacy and Safety of Oxandrolone in Growth Hormone-Treated Girls with Turner Syndrome. The Journal of Clinical Endocrinology & Metabolism. 95(3). 1151–1160. 65 indexed citations

Arends, Nicolette J. T., Venje Boonstra, Paul Mulder, et al.. (2003). GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3‐year results of a randomized, controlled GH trial. Clinical Endocrinology. 59(6). 779–787. 73 indexed citations

Pareren, Yvonne van, Paul Mulder, Mieke Houdijk, et al.. (2003). Effect of Discontinuation of Growth Hormone Treatment on Risk Factors for Cardiovascular Disease in Adolescents Born Small for Gestational Age. The Journal of Clinical Endocrinology & Metabolism. 88(1). 347–353. 70 indexed citations

Vermeer, Harry, C.E. van den Brink, Paul T. van der Saag, et al.. (2003). A novel specific bioassay for the determination of glucocorticoid bioavailability in human serum. Clinical Endocrinology. 59(1). 49–55. 12 indexed citations

Wit, Jan-Maarten, et al.. (2001). Dehydroepiandrosterone Sulfate Treatment for Atrichia pubis. Hormone Research in Paediatrics. 56(3-4). 134–139. 7 indexed citations

Kamp, Gerdine A., Dick Mul, J. J. J. Waelkens, et al.. (2001). A Randomized Controlled Trial of Three Years Growth Hormone and Gonadotropin-Releasing Hormone Agonist Treatment in Children with Idiopathic Short Stature and Intrauterine Growth Retardation¹. The Journal of Clinical Endocrinology & Metabolism. 86(7). 2969–2975. 41 indexed citations

10.

Augustijn, Kevin D., et al.. (2001). Combined Pituitary Hormone Deficiency Caused by Compound Heterozygosity for Two Novel Mutations in the POU Domain of the PIT1/POU1F1 Gene¹. The Journal of Clinical Endocrinology & Metabolism. 86(4). 1545–1550. 42 indexed citations

11.

Jansen, Casper, et al.. (2000). A Novel Nonsense Mutation of the KAL Gene in Two Brothers withKallmann Syndrome. Hormone Research in Paediatrics. 53(4). 207–212. 28 indexed citations

12.

Sas, Theo, Sabine M.P.F. de Muinck Keizer‐Schrama, M. Jansen, et al.. (1999). Normalization of Height in Girls with Turner Syndrome after Long-Term Growth Hormone Treatment: Results of a Randomized Dose-Response Trial¹. The Journal of Clinical Endocrinology & Metabolism. 84(12). 4607–4612. 124 indexed citations

13.

Sas, Theo, Paul Mulder, Mieke Houdijk, et al.. (1999). Growth Hormone Treatment in Children with Short Stature Born Small for Gestational Age: 5-Year Results of a Randomized, Double-Blind, Dose-Response Trial¹. The Journal of Clinical Endocrinology & Metabolism. 84(9). 3064–3070. 163 indexed citations

14.

Teunenbroek, A van, S M de Muinck Keizer-Schrama, T. Stijnen, et al.. (1996). Yearly stepwise increments of the growth hormone dose results in a better growth response after four years in girls with Turner syndrome. Dutch Working Group on Growth Hormone.. The Journal of Clinical Endocrinology & Metabolism. 81(11). 4013–4021. 27 indexed citations

15.

Massa, G., B.J. Otten, M. Jansen, et al.. (1995). Treatment with Two Growth Hormone Regimens in Girls with Turner Syndrome: Final Height Results. Hormone Research. 43(4). 144–146. 34 indexed citations

16.

Moor, Cornelia H. de, M. Jansen, Edgar Bonte, et al.. (1994). Influence of the Four Leader Sequences of the Human Insulin‐Like‐Growth‐Factor‐2 mRNAs on the Expression of Reporter Genes. European Journal of Biochemistry. 226(3). 1039–1047. 11 indexed citations

17.

Pagter-Holthuizen, P. de, et al.. (1989). The human somatomedin/insulin‐like growth factor genes: organization and development‐specific expression. Journal of Internal Medicine. 225(1). 37–42. 5 indexed citations

18.

Tannenbaum, Charles S., T J Koerner, M. Jansen, & Thomas A. Hamilton. (1988). Characterization of lipopolysaccharide-induced macrophage gene expression.. The Journal of Immunology. 140(10). 3640–3645. 83 indexed citations

19.

Pagter-Holthuizen, P. de, M. Jansen, Rob A. van der Kammen, F.M.A. van Schaik, & J.S. Sussenbach. (1988). Differential expression of the human insulin-like growth factor II gene Characterization of the IGF-II mRNAs and an mRNA encoding a putative IGF-II-associated protein. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 950(3). 282–295. 128 indexed citations

20.

Brande, J. L. Van den, M. Jansen, C. M. Hoogerbrugge, et al.. (1986). Molecular Aspects of the Human Somatomedins. Hormone Research. 24(2-3). 131–140. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact